Literature DB >> 16286161

High-density lipoprotein function recent advances.

Benjamin J Ansell1, Karol E Watson, Alan M Fogelman, Mohamad Navab, Gregg C Fonarow.   

Abstract

Although high-density lipoproteins (HDL) possess many features that contribute to the association between elevated HDL cholesterol and protection from atherosclerosis, these lipoproteins may be modified in certain individuals and/or circumstances to become proinflammatory. The ability of HDL to inhibit or paradoxically to enhance vascular inflammation, lipid oxidation, plaque growth, and thrombosis reflects changes in specific enzyme and protein components. The anti-inflammatory and proinflammatory functional properties of HDL can now be assessed using cell-based and cell-free assays. Acute or chronic systemic inflammation and the metabolic syndrome appear to render HDL proinflammatory. In contrast, statins and experimental agents such as apolipoprotein A-1 mimetics render HDL more anti-inflammatory. Functional characterization of HDL is a promising method for enhanced assessment of cardiovascular risk and effectiveness of risk reduction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16286161     DOI: 10.1016/j.jacc.2005.06.080

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  63 in total

1.  The role of HDL in innate immunity.

Authors:  Kenneth R Feingold; Carl Grunfeld
Journal:  J Lipid Res       Date:  2010-10-13       Impact factor: 5.922

2.  Speciated human high-density lipoprotein protein proximity profiles.

Authors:  Kekulawalage Gauthamadasa; Corina Rosales; Henry J Pownall; Stephen Macha; W Gray Jerome; Rong Huang; R A Gangani D Silva
Journal:  Biochemistry       Date:  2010-11-23       Impact factor: 3.162

3.  High-Density Lipoprotein (HDL) Phospholipid Content and Cholesterol Efflux Capacity Are Reduced in Patients With Very High HDL Cholesterol and Coronary Disease.

Authors:  Anandita P Agarwala; Amrith Rodrigues; Marjorie Risman; Mary McCoy; Kevin Trindade; Liming Qu; Marina Cuchel; Jeffrey Billheimer; Daniel J Rader
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-04-02       Impact factor: 8.311

4.  HDL proteomics: pot of gold or Pandora's box?

Authors:  Muredach P Reilly; Alan R Tall
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

5.  Effects of rosuvastatin on electronegative LDL as characterized by capillary isotachophoresis: the ROSARY Study.

Authors:  Bo Zhang; Akira Matsunaga; David L Rainwater; Shin-Ichiro Miura; Keita Noda; Hiroaki Nishikawa; Yoshinari Uehara; Kazuyuki Shirai; Masahiro Ogawa; Keijiro Saku
Journal:  J Lipid Res       Date:  2008-12-03       Impact factor: 5.922

6.  Featured Article: Alterations of lecithin cholesterol acyltransferase activity and apolipoprotein A-I functionality in human sickle blood.

Authors:  Eric Soupene; Mark S Borja; Mauricio Borda; Sandra K Larkin; Frans A Kuypers
Journal:  Exp Biol Med (Maywood)       Date:  2016-06-27

7.  Oxidative mechanisms and atherothrombotic cardiovascular disease.

Authors:  Jane A Leopold; Joseph Loscalzo
Journal:  Drug Discov Today Ther Strateg       Date:  2008-03

8.  Coronary artery diseases in South Asian immigrants: an update on high density lipoprotein role in disease prevention.

Authors:  Sunita Dodani
Journal:  J Immigr Minor Health       Date:  2008-09-24

9.  HDL Mimetic Peptide Administration Improves Left Ventricular Filling and Cardiac output in Lipopolysaccharide-Treated Rats.

Authors:  Geeta Datta; Himanshu Gupta; Zhenghao Zhang; Palgunachari Mayakonda; G M Anantharamaiah; C Roger White
Journal:  J Clin Exp Cardiolog       Date:  2011-12-22

Review 10.  Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis.

Authors:  Matthias Briel; Ignacio Ferreira-Gonzalez; John J You; Paul J Karanicolas; Elie A Akl; Ping Wu; Boris Blechacz; Dirk Bassler; Xinge Wei; Asheer Sharman; Irene Whitt; Suzana Alves da Silva; Zahira Khalid; Alain J Nordmann; Qi Zhou; Stephen D Walter; Noah Vale; Neera Bhatnagar; Christopher O'Regan; Edward J Mills; Heiner C Bucher; Victor M Montori; Gordon H Guyatt
Journal:  BMJ       Date:  2009-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.